Company Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.
The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.
The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.
STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
| Country | United States |
| Founded | 1982 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 1,157 |
| CEO | Stephen Farrell |
Contact Details
Address: 25510 Commercentre Drive Lake Forest, California 92630 United States | |
| Phone | 626 303 7902 |
| Website | staar.com |
Stock Details
| Ticker Symbol | STAA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000718937 |
| CUSIP Number | 852312305 |
| ISIN Number | US8523123052 |
| Employer ID | 95-3797439 |
| SIC Code | 3851 |
Key Executives
| Name | Position |
|---|---|
| Stephen C. Farrell CFA | Chief Executive Officer and Director |
| Warren Foust | President and Chief Operating Officer |
| Nathaniel B. Sisitsky Esq. | Senior Vice President, Chief Legal Officer, General Counsel and Corporate Secretary |
| Dr. Magda Michna Ph.D. | Chief Development Officer |
| Thomas G. Frinzi | Advisor |
| Deborah J. Andrews | Chief Financial Officer |
| Nancy Sabin | Chief Marketing Officer |
| Dr. Scott D. Barnes M.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 15, 2025 | SCHEDULE 13G/A | Filing |
| Aug 8, 2025 | SCHEDULE 13D/A | Filing |
| Aug 6, 2025 | 10-Q | Quarterly Report |
| Aug 6, 2025 | 8-K | Current Report |
| Aug 6, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Aug 5, 2025 | 144 | Filing |
| Aug 5, 2025 | 144 | Filing |
| Aug 5, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Aug 5, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Aug 5, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |